FACIAL IMPLANTS

TECHNOLOGY

Unique Swedish Research Behind An Innovation in Filler Technology

For many years the traditional cross-linked Hyaluronic Acid of non-animal origin has been proven substance in dermal fillers and has been shown to be very safe and effective. We have now taken the development further. Thanks to our innovative spherification technology, a result of many years of Swedish research, we can now introduce a Hyaluronic Acid based dermal filler with smooth spherical particles instead of the traditional structure with angular rhomboids.

SCBI (Specialized Cross-linked, Based on non-animal, Improved density and elasticity Sodium Hyaluronic Acid)

SCBI Technology guarantees 3 values for Tulisma:

Enhanced Safety: Tulisma Fillers passed 1st, 2nd and 3rd clinical trials and it’s safety was officially approved by the EU notified body for CE under directive 93/42/EEC for medical devices grade III.

Long-lasting Effect: High cross-linking rate, high molecular HA and spherical technology ensure an outstanding long-lasting effect.

High Satisfaction: Approved clinical data and patient satisfaction reports proves that Tulisma’s HA Filler customer are among the most satisfied customers.

TULISMA ESSENCE

Every Tulisma filler has been meticulously engineered to provide a specific rheology for precise
treatment of a wide variety of individualized aesthetic needs.